TY - JOUR
T1 - Real-World Outcomes of Neoadjuvant Pembrolizumab plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Multicenter Study from Türkiye
Y1 - 2026
PY - 2026
DA - 2026
N1 - doi:266171
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 171
EP - 178
VL - 10
IS - 2
SN - 
M3 - doi:266171
UR - https://dx.doi.org/10.14744/ejmi.266171
Y2 - 2026
ER -